Shanghai Chest Hospital — Shanghai, Shanghai Municipality

Public research footprint of Shanghai Chest Hospital, compiled from the ClinicalTrials.gov public registry.

549

Registered studies

277

Active

154

Recruiting now

128

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Esophageal Squamous Cell Carcinoma (ESCC)

Recently updated registry entries

NCT06772623 — Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab… (Recruiting)
NCT05067283 — A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001) (Recruiting)
NCT04656652 — Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Shanghai Chest Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.